forums

Forums
Each WNYVA forum features presentations by two companies that are seeking private equity investment.

Presenters are pre-screened and are some of the up-and-coming businesses in our region. Our forums also present the opportunity to network with angel investors, venture capital firms and other business professionals. Non-members are welcome.

Next Forum: Wednesday, June 10, 2009

The Buffalo Club, 388 Delaware Avenue, Buffalo, NY (Business Attire Required)

Cost (includes continental breakfast):
Members and 1st time guests of members – Free
Non-members - $20.00

RSVP: Jack McGowan or Andrea Mayer at 636-3626 or info@wnyventure.com

Program:
7:30 - 8:00 AM Registration, Continental Breakfast, Informal Networking
8:00 - 8:10 AM Attendee Self-Introductions & One-Minute Presenters
8:10 - 9:00 AM Business Plan Presentations and Audience Critique

Presenters:

LifeCellDx, Inc. - Lani J. Burkman, founder; Jeffrey O. Dann, President; John M. Moran, Jr., EVP

LifeCell Dx, Inc. (“LCDX”) uses proprietary methods and the power of the Internet to provide state-of-the-art male infertility testing to couples. The infertility market presents an outstanding opportunity with 10 million infertile couples in the U.S. and Canada, and one in five couples worldwide. Experts estimate that 15% of all younger couples will seek help in having a child --- this will include obtaining one or more semen analyses.

About half of all infertility is caused by sperm problems. Couples want to know if his sperm can produce a pregnancy. They want answers and options. The problems include lack of expert male infertility training in most laboratories, distance from the nearest andrology lab, and the fact that semen must be analyzed within 1-2 hours. Additionally, the standard, basic semen analysis offered at thousands of simple laboratories cannot predict whether the man’s sperm could fertilize an egg.

Now, using simple, inexpensive equipment at a clinic or physician's office, LCDX can quickly analyze transmitted videos of sperm samples to provide a detailed fertility report to couples and physicians. The company’s expert LCPredict™ report gives physicians and couples detailed information that is 90% reliable in predicting pregnancy potential. LifeCell Dx is the first business worldwide to offer advanced semen analysis using sperm video transmission through the Internet (e-fertility diagnostics). Both our "e-fertility diagnostic" approach and LCPredict™ test has been approved by the New York State Department of Health.

LifeCellDx is seeking $1 million of financing to fund the personnel, equipment and working capital required to expand service delivery.

Oral Health Innovations - David Dugan, MD, DDS, Founder & Eric Cornavaca, Chief Executive Officer

Oral Health Innovations has invented a hands free automated tooth brushing system. This Class I medical device requires little or no dexterity, can be hands-free, is fun to use, is fast, and most importantly is effective.

This device will assist people with limited dexterity, in brushing their teeth. Individuals with arthritis, stroke, dementia, progressive neurological disease, or developmental disabilities often have a very difficult time brushing their teeth. As a result they suffer a higher rate of decay than the rest of the population. These individuals have limited access to care due to their disabilities, and lack of income at a time when they need it the most. In many instances, a family member or nurse’s aid has to brush the teeth of the disabled person (a very difficult task).

OHI’s business strategy has 2 components. The first is to go direct to the assistive living, nursing home market. The second is to seek partnership with major suppliers such as Proctor & Gamble, Phillips, and others, and establish licensing and/or distribution agreements to take this technology to the mass consumer markets. This will give OHI broad reach and aggressive penetration rates for this invention.

OHI filed a non provisional patent in May 2009 that allows us to protect and license our technology to valued partners. OHI is developing additional intellectual property, trade secrets, and process know-how around its core brushing technology. The present invention broadly comprises a tooth brushing system adapted to simultaneously clean a set of maxilla teeth or a set of mandible teeth.

The company is currently seeking $1.4 Million to complete R&D & Clinical Trials by early 2010 as well as funding of commercial launch activities. Market entry is expected around 2Q 2010. The Company has received $300K in private funds as well as $80K in public funds to date.

Western New York Venture Association
726 Exchange St., Suite 620 | Buffalo, NY 14210
Phone: 716-636-3626 Fax: 716-845-6418
E-mail: info@wnyventure.com